Elkfork Partners’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $200K | Buy |
3,332
+272
| +9% | +$16.3K | ﹤0.01% | 826 |
|
|
2019
Q2 | $258K | Hold |
3,060
| – | – | 0.01% | 760 |
|
|
2019
Q1 | $292K | Hold |
3,060
| – | – | 0.01% | 709 |
|
|
2018
Q4 | $217K | Hold |
3,060
| – | – | 0.01% | 744 |
|
|
2018
Q3 | $261K | Buy |
3,060
+952
| +45% | +$81.2K | 0.01% | 780 |
|
|
2018
Q2 | $244K | Hold |
2,108
| – | – | 0.01% | 733 |
|
|
2018
Q1 | $171K | Buy |
+2,108
| New | +$171K | ﹤0.01% | 831 |
|
|
2017
Q1 | – | Sell |
-680
| Closed | -$23K | – | 1005 |
|
|
2016
Q4 | $23K | Buy |
+680
| New | +$23K | ﹤0.01% | 962 |
|